Td Waterhouse Canada Inc. Biomarin Pharmaceutical Inc Transaction History

Td Waterhouse Canada Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$76.22 - $98.51 $74,162 - $95,850	973 New	973 $95.1 Million
Q2 2023 Nov 13, 2023	SELL	$86.68 - $100.3 $866 - $1,003	-10 Closed	0 $0
Q1 2023 Nov 13, 2023	BUY	$87.74 - $117.27 $877 - $1,172	10 New	10 $1.3 Million
Q4 2022 Nov 13, 2023	SELL	$80.93 - $108.63 $48,558 - $65,178	-600 Closed	0 $0
Q2 2022 Nov 13, 2023	SELL	$71.48 - $86.85 $929 - $1,129	-13 Reduced 2.12%	600 $51 Million
Q1 2022 Nov 13, 2023	BUY	$74.28 - $92.69 $965 - $1,204	13 Added 2.17%	613 $48.6 Million
Q4 2021 Nov 13, 2023	BUY	$71.72 - $91.47 $43,032 - $54,882	600 New	600 $52.3 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.